论文部分内容阅读
目的观察硝苯地平联合川芎嗪治疗肺源性心脏病心力衰竭的疗效和心功能改善情况。方法选取肺源性心脏病心力衰竭患者94例,随机分为两组。对照组(48例)给予持续低流量吸氧、抗感染、平喘、祛痰、强心、利尿及对症支持等常规治疗。观察组(46)例在常规治疗基础上联合应用硝苯地平缓释片以及川芎嗪治疗。观察两组疗效。结果观察组显效28例(61%),有效15例(32%),无效3例(7%);对照组显效10例(21%),有效23例(48%),无效15例(31%),两组显效率比较差异有统计学意义。结论 硝苯地平联合川芎嗪治疗肺源性心脏病疗效可靠。
Objective To observe the curative effect and heart function improvement of nifedipine combined with ligustrazine on patients with heart failure of pulmonary heart disease. Methods 94 cases of heart failure patients with pulmonary heart disease were randomly divided into two groups. The control group (48 cases) received continuous low-flow oxygen therapy, anti-infection, antiasthmatic, expectorant, cardiac, diuretic and symptomatic support and other routine treatment. Observation group (46 cases) on the basis of conventional treatment combined with nifedipine sustained release tablets and ligustrazine treatment. The two groups were observed. Results The observation group was significantly improved in 28 cases (61%), effective in 15 cases (32%) and ineffective in 3 cases (7%). The control group was markedly effective in 10 cases (21%), effective in 23 cases %), Significant difference between the two groups was statistically significant. Conclusion Nifedipine combined with ligustrazine in the treatment of pulmonary heart disease is reliable.